Risk adjusted net present value: What is the current valuation of Bavarian Nordic’s PXVX-0317?

PXVX-0317 is a subunit vaccine commercialized by Bavarian Nordic, with a leading Phase III program in Chikungunya Fever.

Could billions of dollars in AI funding lead to the same number of new drugs?

Drug discovery has quickly become the most enticing place to apply artificial intelligence. Billions of dollars are being invested in AI-driven “techbios.” In an industry

June 25, 2024

Cox Health to Implement Epic Enterprise EHR, Replacing Cerner

What You Should Know: – CoxHealth, a healthcare system in southwest Missouri announced it will implement Epic enterprise EHR across its health system, replacing its

December 19, 2023

DeepScribe Now Available on AWS Marketplace for Streamlined Clinical Documentation

What You Should Know: – DeepScribe, a leading company in ambient AI for clinical documentation, announced today the general availability of its platform on AWS

April 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.